215 related articles for article (PubMed ID: 27794408)
1. Imaging in pleural mesothelioma: A review of the 13th International Conference of the International Mesothelioma Interest Group.
Armato SG; Blyth KG; Keating JJ; Katz S; Tsim S; Coolen J; Gudmundsson E; Opitz I; Nowak AK
Lung Cancer; 2016 Nov; 101():48-58. PubMed ID: 27794408
[TBL] [Abstract][Full Text] [Related]
2. Imaging in pleural mesothelioma: A review of the 12th International Conference of the International Mesothelioma Interest Group.
Armato SG; Coolen J; Nowak AK; Robinson C; Gill RR; Straus C; Khanwalkar A
Lung Cancer; 2015 Nov; 90(2):148-54. PubMed ID: 26298162
[TBL] [Abstract][Full Text] [Related]
3. Imaging in pleural mesothelioma: A review of the 15th International Conference of the International Mesothelioma Interest Group.
Armato SG; Nowak AK; Francis RJ; Katz SI; Kholmatov M; Blyth KG; Gudmundsson E; Kidd AC; Gill RR
Lung Cancer; 2022 Feb; 164():76-83. PubMed ID: 35042132
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced CT for the assessment of tumour response in malignant pleural mesothelioma: a pilot study.
Gudmundsson E; Labby Z; Straus CM; Sensakovic WF; Li F; Rose B; Cunliffe A; Kindler HL; Armato SG
Eur Radiol; 2019 Feb; 29(2):682-688. PubMed ID: 29967955
[TBL] [Abstract][Full Text] [Related]
5. Imaging in pleural mesothelioma: a review of the 11th International Conference of the International Mesothelioma Interest Group.
Armato SG; Labby ZE; Coolen J; Klabatsa A; Feigen M; Persigehl T; Gill RR
Lung Cancer; 2013 Nov; 82(2):190-6. PubMed ID: 24018024
[TBL] [Abstract][Full Text] [Related]
6. Whole-Body MRI: Comparison of Its Capability for TNM Staging of Malignant Pleural Mesothelioma With That of Coregistered PET/MRI, Integrated FDG PET/CT, and Conventional Imaging.
Ohno Y; Yui M; Aoyagi K; Kishida Y; Seki S; Koyama H; Yoshikawa T
AJR Am J Roentgenol; 2019 Feb; 212(2):311-319. PubMed ID: 30512992
[TBL] [Abstract][Full Text] [Related]
7. Dynamic contrast-enhanced MRI of malignant pleural mesothelioma: a comparative study of pharmacokinetic models and correlation with mRECIST criteria.
Vivoda Tomšič M; Bisdas S; Kovač V; Serša I; Šurlan Popovič K
Cancer Imaging; 2019 Feb; 19(1):10. PubMed ID: 30813957
[TBL] [Abstract][Full Text] [Related]
8. Revised Modified Response Evaluation Criteria in Solid Tumors for Assessment of Response in Malignant Pleural Mesothelioma (Version 1.1).
Armato SG; Nowak AK
J Thorac Oncol; 2018 Jul; 13(7):1012-1021. PubMed ID: 29753121
[TBL] [Abstract][Full Text] [Related]
9. Imaging in pleural mesothelioma: a review of imaging research presented at the 9th International Meeting of the International Mesothelioma Interest Group.
Nowak AK; Armato SG; Ceresoli GL; Yildirim H; Francis RJ
Lung Cancer; 2010 Oct; 70(1):1-6. PubMed ID: 20541834
[TBL] [Abstract][Full Text] [Related]
10. Imaging in pleural mesothelioma: A review of the 14th International Conference of the International Mesothelioma Interest Group.
Armato SG; Francis RJ; Katz SI; Ak G; Opitz I; Gudmundsson E; Blyth KG; Gupta A
Lung Cancer; 2019 Apr; 130():108-114. PubMed ID: 30885330
[TBL] [Abstract][Full Text] [Related]
11. A Multicenter Study of Volumetric Computed Tomography for Staging Malignant Pleural Mesothelioma.
Rusch VW; Gill R; Mitchell A; Naidich D; Rice DC; Pass HI; Kindler HL; De Perrot M; Friedberg J;
Ann Thorac Surg; 2016 Oct; 102(4):1059-66. PubMed ID: 27596916
[TBL] [Abstract][Full Text] [Related]
12. Positron Emission Tomography/Computed Tomography for the Pleural Staging of Malignant Pleural Mesothelioma: How Accurate Is It?
Pinelli V; Roca E; Lucchini S; Laroumagne S; Loundou A; Dutau H; Maldonado F; Astoul P
Respiration; 2015; 89(6):558-64. PubMed ID: 25966972
[TBL] [Abstract][Full Text] [Related]
13. Current state and future directions of pleural mesothelioma imaging.
Armato SG; Entwisle J; Truong MT; Nowak AK; Ceresoli GL; Zhao B; Misri R; Kindler HL
Lung Cancer; 2008 Mar; 59(3):411-20. PubMed ID: 18061303
[TBL] [Abstract][Full Text] [Related]
14. North American Multicenter Volumetric CT Study for Clinical Staging of Malignant Pleural Mesothelioma: Feasibility and Logistics of Setting Up a Quantitative Imaging Study.
Gill RR; Naidich DP; Mitchell A; Ginsberg M; Erasmus J; Armato SG; Straus C; Katz S; Patios D; Richards WG; Rusch VW;
J Thorac Oncol; 2016 Aug; 11(8):1335-1344. PubMed ID: 27180318
[TBL] [Abstract][Full Text] [Related]
15. Three-dimensional stereoscopic volume rendering of malignant pleural mesothelioma.
Mollberg NM; Parsad NM; Armato SG; Vigneswaran J; Kindler HL; Sensakovic WF; Salgia R; Silverstein JC; Vigneswaran WT
Int Surg; 2012; 97(1):65-70. PubMed ID: 23102002
[TBL] [Abstract][Full Text] [Related]
16. 18F-Fluorodeoxyglucose PET/CT and dynamic contrast-enhanced MRI as imaging biomarkers in malignant pleural mesothelioma.
Hall DO; Hooper CE; Searle J; Darby M; White P; Harvey JE; Braybrooke JP; Maskell NA; Masani V; Lyburn ID
Nucl Med Commun; 2018 Feb; 39(2):161-170. PubMed ID: 29300270
[TBL] [Abstract][Full Text] [Related]
17. Computed tomography in the evaluation of malignant pleural mesothelioma-Association of tumor size to a sarcomatoid histology, a more advanced TNM stage and poor survival.
Paajanen J; Laaksonen S; Ilonen I; Wolff H; Husgafvel-Pursiainen K; Kuosma E; Ollila H; Myllärniemi M; Vehmas T
Lung Cancer; 2018 Feb; 116():73-79. PubMed ID: 29413055
[TBL] [Abstract][Full Text] [Related]
18. Optimal gross tumor volume definition in lung-sparing intensity modulated radiotherapy for pleural mesothelioma: an in silico study.
Botticella A; Defraene G; Nackaerts K; Deroose CM; Coolen J; Nafteux P; Peeters S; Ricardi U; De Ruysscher D
Acta Oncol; 2016 Dec; 55(12):1450-1455. PubMed ID: 27732127
[TBL] [Abstract][Full Text] [Related]
19. Response evaluation in mesothelioma: Beyond RECIST.
Cheng L; Tunariu N; Collins DJ; Blackledge MD; Riddell AM; Leach MO; Popat S; Koh DM
Lung Cancer; 2015 Dec; 90(3):433-41. PubMed ID: 26443279
[TBL] [Abstract][Full Text] [Related]
20. Optimization of response classification criteria for patients with malignant pleural mesothelioma, a validation study.
Buikhuisen WA; Qayyum F; Armato SG; Baas P
Lung Cancer; 2019 Dec; 138():139-140. PubMed ID: 31733933
[No Abstract] [Full Text] [Related]
[Next] [New Search]
